Intranasal Dexmedetomidine for Procedural Sedation in Children, a Suitable Alternative to Chloral Hydrate
- 512 Downloads
Sedation is often required for children undergoing diagnostic procedures. Chloral hydrate has been one of the sedative drugs most used in children over the last 3 decades, with supporting evidence for its efficacy and safety. Recently, chloral hydrate was banned in Italy and France, in consideration of evidence of its carcinogenicity and genotoxicity. Dexmedetomidine is a sedative with unique properties that has been increasingly used for procedural sedation in children. Several studies demonstrated its efficacy and safety for sedation in non-painful diagnostic procedures. Dexmedetomidine’s impact on respiratory drive and airway patency and tone is much less when compared to the majority of other sedative agents. Administration via the intranasal route allows satisfactory procedural success rates. Studies that specifically compared intranasal dexmedetomidine and chloral hydrate for children undergoing non-painful procedures showed that dexmedetomidine was as effective as and safer than chloral hydrate. For these reasons, we suggest that intranasal dexmedetomidine could be a suitable alternative to chloral hydrate.
KeywordsDexmedetomidine Chloral Hydrate Sedative Agent Procedural Sedation Intranasal Route
All authors, SN, GC and EB, contributed equally to the manuscript. All authors, SN, GC and EB, read and approved the manuscript and approved its submission to the journal.
Compliance with Ethical Standards
Conflict of interest
The authors SN, GC and EB declare that they do not have any conflict of interest.
The authors, SN, GC and EB, declare they did not receive any funding or grant for this manuscript.
- 6.D’agostino J, Terndrup TE. Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatr Emerg Care. 2000;16:1–4.Google Scholar
- 11.Buck ML. The use of chloral hydrate in infants and children. Pediatr Pharmacother. 2005;11:1–4.Google Scholar
- 14.Mace SE, Brown LA, Francis L, Godwin SA, Hahn SA, Howard PK, et al. EMCS Panel on Critical Issues in the Sedation of Pediatric Patients in the Emergency Department Clinical policy: critical issues in the sedation of pediatric patients in the emergency department. Ann Emerg Med. 2008;51:378–99.CrossRefPubMedGoogle Scholar
- 20.Faritus SZ, Khazaee-Koohpar M, Ziyaeifard M, Mehrabanian MJ. Oral dexmedetomidine versus midazolam as anesthetic premedication in children undergoing congenital heart surgery. Anesth Pain Med. 2015;22:e25032.Google Scholar
- 21.Tobias JD, Cravero JP. Procedural sedation for infants, children and adolescents. First ed. American Academy of Pediatrics section on Anesthesiology and Pain Medicine; 2016.Google Scholar
- 25.US Food and Drug Administration. Safety Announcement: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. 2016; Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM533197.pdf. Accessed 24 Jan 2017.
- 28.Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, et al. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology. 2013;118:1123–32.CrossRefPubMedGoogle Scholar